OR WAIT null SECS
The company announced that it is fully compliant with the 2017–2023 serialization and aggregation requirements.
On June 5, 2017, Mikart announced that it is fully compliant with 2017–2023 serialization and aggregation requirements in the Drug Supply Chain Security Act. The Atlanta-based company has partnered with Optel Vision, which makes hardware and software that generates, reads, applies, and verifies codes throughout the entire packaging process, and TraceLink, the data warehouse that makes information contained in the serialization codes available to every point in the pharmaceutical supply chain.
Mikart offers a full range of services in addition to serialization and aggregation, including pharmaceutical development, clinical trial manufacturing and packaging, regulatory submissions, commercial scale manufacturing, and packaging solutions.